Key facts
- Mitra Bio’s last known valuation is $24.0M (Dec 2024).
- It has raised $7.7M.
- Notable investors include Innovate UK, European Innovation Council, Khosla Ventures, Entrepreneurs First, University of Oxford — 11 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 11 names
- ·Watchlist + deal alerts for Mitra Bio
- ·The full record, as it builds
Funding rounds
No funding rounds for Mitra Bio are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Mitra Bio
Operator of a skin diagnostics platform intended to power the development of age-rejuvenating compounds. The company uses non-invasive skin sampling, next-generation sequencing and data science to extract omics data from the skin during clinical trials, enabling clients to get information on the development of novel treatments for skin longevity.
- Sector
- Healthcare
- HQ
- London, United Kingdom
- Founded
- 2020
- Employees
- 13
- Website
- mitrabio.tech/
- Ownership
- Privately Held (backing)
Mitra Bio doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Mitra Bio shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Mitra Bio in its N-PORT filings yet. We sweep new filings monthly.